Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPDTIC vs CAPTEM in Neuroendocrine Tumors
NCT03279601Phase 2Unknown
- Sponsor
- Peking University
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dacarbazine in gastrointestinal neuroendocrine tumor, Pancreatic neuroendocrine tumor (PanNET), esophageal neuroendocrine tumor (eNET), sponsored by Peking University. Status: unknown.
02
Drugs
dacarbazine
03
Conditions
gastrointestinal neuroendocrine tumorPancreatic neuroendocrine tumor (PanNET)esophageal neuroendocrine tumor (eNET)
Beyond the preview
Go deeper on NCT03279601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279601.